查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1713577

2025年全球血管內血管支架市場報告

Endovascular Stent Grafts Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年血管內血管支架市場的規模將呈指數級成長。預計到 2029 年將成長至 51.9 億美元，複合年成長率為 37.6%。預測期內的成長歸因於向微創手術的持續轉變、動脈粥樣硬化和肺動脈栓塞等血管疾病的增加、有利的報銷政策、醫院數量的增加以及年輕一代糖尿病的增加。預測期內的關鍵趨勢包括人工智慧的整合、先進成像技術的創新、針對特定患者或可客製化的血管支架的開發、下一代組織工程血管移植物的開發以及技術進步。

心血管疾病盛行率的上升預計將推動未來血管內血管支架市場的成長。心血管疾病 (CVD) 包括一系列影響心臟和血管的疾病。這些疾病的盛行率不斷上升，是由多種因素造成的，包括生活方式選擇、醫療狀況、遺傳傾向和環境影響。血管內血管支架透過專注於微創手術和改善患者預後，為心血管疾病提供了有效的治療選擇。這些血管支架可加強脆弱的血管壁，防止破裂並降低危及生命的併發症的風險。例如，2023年12月，澳洲政府機構澳洲健康與福利研究所的數據顯示，醫生認證的心臟疾病（CHD）死亡人數從2021年的14,100人增加到2022年的14,900人。因此，心血管疾病盛行率的上升正在推動血管內血管支架市場的成長。

血管內血管支架市場的主要企業正專注於開發胸主動脈血管支架等創新產品，以提高胸主動脈瘤和夾層治療的精確度和有效性。這些進步旨在透過先進的技術和改進的設計來改善患者的治療效果並解決複雜的解剖挑戰。胸主動脈血管支架是一種用於血管內手術治療胸主動脈（位於胸部的主動脈部分）疾病的專用裝置。它集治療胸主動脈疾病的安全性、有效性和便利性於一體。例如，2024年2月，中國醫療設備公司心脈醫療推出多分支胸主動脈覆膜支架系統（Hector），並在瑞士首次實現臨床應用。 Hector 系統代表了血管內血管支架技術的重大進步，透過保留和調整為重要器官供血的重要主動脈分支，可以治療複雜的胸主動脈疾病。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球血管內血管支架市場 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
  • 最終用途產業分析
  • 全球血管內血管支架市場：成長率分析
  • 全球血管內血管支架市場表現：規模與成長，2019-2024
  • 全球血管內血管支架市場預測：規模與成長，2024-2029，2034
  • 全球血管內血管支架總目標市場（TAM）

第6章市場區隔

  • 全球血管內血管支架市場（按產品、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 血液透析機通路移植物
  • 血管內血管支架
  • 冠狀動脈繞道手術
  • 主動脈疾病的血管移植
  • 周邊血管移植
  • 全球血管內血管支架市場（依材料、效能及預測），2019-2024 年、2024-2029 年、2034 年
  • 合成血管移植物
  • 生物血管移植
  • 混合血管移植物
  • 全球血管內血管支架市場應用、績效及預測（2019-2024、2024-2029、2034）
  • 心臟動脈瘤
  • 腎衰竭
  • 血管閉塞
  • 冠狀動脈疾病
  • 全球血管內血管支架市場：血液透析機通路移植物按類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 動靜脈（AV）移植物
  • 合成血液血液透析機通路移植物
  • 生物工程血液透析機通路移植物
  • 塗層血液透析機移植物
  • 血管內血液透析機移植物
  • 全球血管內血管支架市場：按類型、性能和預測對血管內血管支架進行細分，2019-2024 年、2024-2029 年、2034 年
  • 動脈瘤支架血管支架
  • 主動脈剝離血管支架
  • 胸腔血管內血管支架
  • 腹部血管內血管支架
  • 膽道血管內血管支架
  • 全球血管內支架血管支架市場：冠狀動脈繞道手術手術細分（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 隱靜脈移植（SVG）
  • 冠狀動脈冠狀動脈繞道手術
  • 血管內冠狀動脈繞道手術（CABG）
  • 合成冠狀動脈繞道手術手術
  • 全球血管內血管支架市場：主動脈疾病血管移植按類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 主動脈血管支架
  • 主動脈瘤移植
  • 主動脈繞道手術
  • 胸腹主動脈血管支架
  • 主動脈剝離血管支架
  • 全球血管內支架血管支架市場：周邊血管移植細分市場（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 頸動脈血管支架
  • 股動脈血管支架
  • 膕動脈血管支架
  • 髂動脈支架血管支架物
  • 周邊血管內血管支架

第7章 區域和國家分析

  • 全球血管內血管支架市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球血管內血管支架市場（依國家/地區、績效及預測）2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 血管內血管支架市場：競爭格局
  • 血管內血管支架市場：公司簡介
    • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Becton, Dickinson and Company（BD）Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Boston Scientific Corporation
  • Terumo Corporation
  • Getinge AB
  • Cook Group Incorporated
  • Merit Medical Systems Inc.
  • Biotronik SE & Co KG
  • MicroPort Scientific Corporation
  • Endologix LLC
  • LeMaitre Vascular Inc.
  • Lifetech Scientific Corporation
  • WL Gore & Associates inc.
  • Braile Biomedica
  • BrosMed Medical BV
  • Micro Interventional Devices Inc.（MID）
  • Lombard Medical Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029 年血管內血管支架市場：提供新機會的國家
  • 2029年血管內血管支架市場：細分市場帶來新機會
  • 2029 年血管內血管支架市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r33479

Endovascular stent grafts are medical devices used to address conditions affecting blood vessels, such as aneurysms or stenosis. They comprise a metal stent a small mesh tube covered with a fabric graft. The stent graft is introduced into the affected blood vessel via a catheter, usually inserted into a large artery in the groin or arm. These devices frequently repair aneurysms (enlarged sections of blood vessels) or other vessel damage, providing a less invasive alternative to traditional surgery.

The primary types of endovascular stent grafts include hemodialysis access grafts, endovascular stent grafts, coronary artery bypass grafts, vascular grafts for aorta diseases, and peripheral vascular grafts. Hemodialysis access grafts are specifically designed to provide an access point for hemodialysis in patients with kidney failure. Various materials, including synthetic, biological, and hybrid vascular grafts, are utilized in different applications such as cardiac aneurysms, kidney failure, vascular occlusion, and coronary artery diseases.

The endovascular stent grafts market research report is one of a series of new reports from The Business Research Company that provides endovascular stent grafts market statistics, including endovascular stent grafts industry global market size, regional shares, competitors with an endovascular stent grafts market share, detailed endovascular stent grafts market segments, market trends, and opportunities, and any further data you may need to thrive in the endovascular stent grafts industry. This endovascular stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The endovascular stent grafts market size has grown exponentially in recent years. It will grow from $1.05 billion in 2024 to $1.45 billion in 2025 at a compound annual growth rate (CAGR) of 37.8%. The growth in the historic period can be attributed to rise in the incidence of aortic aneurysms, rising aging population, increasing healthcare spending in developed regions, rise in number of ambulatory surgical centers, and rising incidence of chronic disease.

The endovascular stent grafts market size is expected to see exponential growth in the next few years. It will grow to $5.19 billion in 2029 at a compound annual growth rate (CAGR) of 37.6%. The growth in the forecast period can be attributed to ongoing shift towards minimally invasive procedures, increase in vascular diseases such as atherosclerosis, and pulmonary embolism, favorable reimbursement policies, increase in number of hospitals, and increasing diabetes even in the young generation. Major trends in the forecast period include integrating artificial intelligence, innovating advanced imaging technologies, developing of patient-specific or customizable stent grafts, developing of next-generation tissue-engineered vascular grafts, and technology advancements.

The rising prevalence of cardiovascular diseases is expected to boost the growth of the endovascular stent graft market in the future. Cardiovascular disease (CVD) encompasses a range of conditions affecting the heart and blood vessels. The increasing incidence of these diseases is attributed to various factors, including lifestyle choices, medical conditions, genetic predispositions, and environmental influences. Endovascular stent grafts provide an effective treatment option for cardiovascular diseases by focusing on minimizing invasiveness and enhancing patient outcomes. These stent grafts reinforce weakened vessel walls, preventing ruptures and lowering the risk of life-threatening complications. For example, in December 2023, data from the Australian Institute of Health and Welfare, an Australian government agency, revealed that the number of doctor-certified deaths due to coronary heart disease (CHD) rose from 14,100 in 2021 to 14,900 in 2022. Consequently, the increasing prevalence of cardiovascular diseases is driving the growth of the endovascular stent graft market.

Major companies in the endovascular stent graft market are concentrating on developing innovative products, such as thoracic aortic stent-grafts, to improve the precision and effectiveness of treating thoracic aortic aneurysms and dissections. These advancements aim to enhance patient outcomes and address complex anatomical challenges through advanced technology and design enhancements. A thoracic aortic stent graft is a specialized device used in endovascular surgery to manage diseases of the thoracic aorta, which is the section of the aorta located in the chest. It provides a combination of safety, efficacy, and convenience for treating thoracic aortic conditions. For example, in February 2024, Endovastec, a China-based medical device company, launched the Multi-Branch Thoracic Aortic Stent-Graft System (Hector) and carried out its first clinical application in Switzerland. The Hector system marks a significant step forward in endovascular stent graft technology, featuring a multi-branch design that allows for the treatment of complex thoracic aortic conditions by preserving and accommodating essential aortic branches, including those supplying vital organs.

In August 2022, W. L. Gore & Associates Inc. (Gore), a US-based company specializing in a variety of medical devices, acquired InnAVasc Medical Inc. for an undisclosed sum. This acquisition was strategically intended to strengthen Gore's position in the vascular sector by incorporating InnAVasc's advanced endovascular technologies. InnAVasc Medical Inc., also a US-based firm, is known for its production of endovascular stent grafts.

Major companies operating in the endovascular stent grafts market are Cardinal Health Inc., Abbott Laboratories, Medtronic PLC, Stryker Corporation, Becton, Dickinson and Company (BD), Boston Scientific Corporation, Terumo Corporation, Getinge AB, Cook Group Incorporated, Merit Medical Systems Inc., Biotronik SE & Co KG, MicroPort Scientific Corporation, Endologix LLC, LeMaitre Vascular Inc., Lifetech Scientific Corporation, W. L. Gore & Associates inc., Braile Biomedica, BrosMed Medical BV, Micro Interventional Devices Inc. (MID), Lombard Medical Inc.

North America was the largest region in the endovascular stent grafts market in 2024. The regions covered in the endovascular stent grafts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the endovascular stent grafts market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endovascular stent grafts market consists of sales of aortoiliac stent grafts, thoracic endograft, and abdominal endografts. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endovascular Stent Grafts Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on endovascular stent grafts market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for endovascular stent grafts ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The endovascular stent grafts market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Hemodialysis Access Grafts; Endovascular Stent Grafts; Coronary Artery By-Pass Grafts; Vascular Grafts for Aorta Disease; Peripheral Vascular Grafts
  • 2) By Raw Material: Synthetic Vascular Grafts; Biological Vascular Grafts; Hybrid Vascular Grafts
  • 3) By Application: Cardiac Aneurysm; Kidney Failure; Vascular Occlusion; Coronary Artery Disease
  • Subsegments:
  • 1) By Hemodialysis Access Grafts: Arteriovenous (AV) Fistula Grafts; Synthetic Hemodialysis Access Grafts; Bioengineered Hemodialysis Access Grafts; Coated Hemodialysis Grafts; Endovascular Hemodialysis Grafts
  • 2) By Endovascular Stent Grafts: Aneurysm Stent Grafts; Stent Grafts For Aortic Dissection; Thoracic Endovascular Stent Grafts; Abdominal Endovascular Stent Grafts; Biliary Endovascular Stent Grafts
  • 3) By Coronary Artery By-Pass Grafts: Saphenous Vein Grafts (SVG); Arterial Coronary Bypass Grafts; Endovascular Coronary Artery Bypass Grafts (CABG); Synthetic Coronary Bypass Grafts
  • 4) By Vascular Grafts For Aorta Disease: Endovascular Aortic Stent Grafts; Aortic Aneurysm Grafts; Aortic Bypass Grafts; Thoracoabdominal Aortic Stent Grafts; Aortic Dissection Stent Grafts
  • 5) By Peripheral Vascular Grafts: Carotid Artery Stent Grafts; Femoral Artery Stent Grafts; Popliteal Artery Stent Grafts; Iliac Artery Stent Grafts; Peripheral Endovascular Stent Grafts
  • Companies Mentioned: Cardinal Health Inc.; Abbott Laboratories; Medtronic PLC; Stryker Corporation; Becton, Dickinson and Company (BD)
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Endovascular Stent Grafts Market Characteristics

3. Endovascular Stent Grafts Market Trends And Strategies

4. Endovascular Stent Grafts Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Endovascular Stent Grafts Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Endovascular Stent Grafts PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Endovascular Stent Grafts Market Growth Rate Analysis
  • 5.4. Global Endovascular Stent Grafts Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Endovascular Stent Grafts Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Endovascular Stent Grafts Total Addressable Market (TAM)

6. Endovascular Stent Grafts Market Segmentation

  • 6.1. Global Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hemodialysis Access Grafts
  • Endovascular Stent Grafts
  • Coronary Artery By-Pass Grafts
  • Vascular Grafts For Aorta Disease
  • Peripheral Vascular Grafts
  • 6.2. Global Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Synthetic Vascular Grafts
  • Biological Vascular Grafts
  • Hybrid Vascular Grafts
  • 6.3. Global Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiac Aneurysm
  • Kidney Failure
  • Vascular Occlusion
  • Coronary Artery Disease
  • 6.4. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Hemodialysis Access Grafts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Arteriovenous (AV) Fistula Grafts
  • Synthetic Hemodialysis Access Grafts
  • Bioengineered Hemodialysis Access Grafts
  • Coated Hemodialysis Grafts
  • Endovascular Hemodialysis Grafts
  • 6.5. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Endovascular Stent Grafts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Aneurysm Stent Grafts
  • Stent Grafts For Aortic Dissection
  • Thoracic Endovascular Stent Grafts
  • Abdominal Endovascular Stent Grafts
  • Biliary Endovascular Stent Grafts
  • 6.6. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Coronary Artery By-Pass Grafts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Saphenous Vein Grafts (SVG)
  • Arterial Coronary Bypass Grafts
  • Endovascular Coronary Artery Bypass Grafts (CABG)
  • Synthetic Coronary Bypass Grafts
  • 6.7. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Vascular Grafts For Aorta Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Endovascular Aortic Stent Grafts
  • Aortic Aneurysm Grafts
  • Aortic Bypass Grafts
  • Thoracoabdominal Aortic Stent Grafts
  • Aortic Dissection Stent Grafts
  • 6.8. Global Endovascular Stent Grafts Market, Sub-Segmentation Of Peripheral Vascular Grafts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Carotid Artery Stent Grafts
  • Femoral Artery Stent Grafts
  • Popliteal Artery Stent Grafts
  • Iliac Artery Stent Grafts
  • Peripheral Endovascular Stent Grafts

7. Endovascular Stent Grafts Market Regional And Country Analysis

  • 7.1. Global Endovascular Stent Grafts Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Endovascular Stent Grafts Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Endovascular Stent Grafts Market

  • 8.1. Asia-Pacific Endovascular Stent Grafts Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Endovascular Stent Grafts Market

  • 9.1. China Endovascular Stent Grafts Market Overview
  • 9.2. China Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Endovascular Stent Grafts Market

  • 10.1. India Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Endovascular Stent Grafts Market

  • 11.1. Japan Endovascular Stent Grafts Market Overview
  • 11.2. Japan Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Endovascular Stent Grafts Market

  • 12.1. Australia Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Endovascular Stent Grafts Market

  • 13.1. Indonesia Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Endovascular Stent Grafts Market

  • 14.1. South Korea Endovascular Stent Grafts Market Overview
  • 14.2. South Korea Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Endovascular Stent Grafts Market

  • 15.1. Western Europe Endovascular Stent Grafts Market Overview
  • 15.2. Western Europe Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Endovascular Stent Grafts Market

  • 16.1. UK Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Endovascular Stent Grafts Market

  • 17.1. Germany Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Endovascular Stent Grafts Market

  • 18.1. France Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Endovascular Stent Grafts Market

  • 19.1. Italy Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Endovascular Stent Grafts Market

  • 20.1. Spain Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Endovascular Stent Grafts Market

  • 21.1. Eastern Europe Endovascular Stent Grafts Market Overview
  • 21.2. Eastern Europe Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Endovascular Stent Grafts Market

  • 22.1. Russia Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Endovascular Stent Grafts Market

  • 23.1. North America Endovascular Stent Grafts Market Overview
  • 23.2. North America Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Endovascular Stent Grafts Market

  • 24.1. USA Endovascular Stent Grafts Market Overview
  • 24.2. USA Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Endovascular Stent Grafts Market

  • 25.1. Canada Endovascular Stent Grafts Market Overview
  • 25.2. Canada Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Endovascular Stent Grafts Market

  • 26.1. South America Endovascular Stent Grafts Market Overview
  • 26.2. South America Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Endovascular Stent Grafts Market

  • 27.1. Brazil Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Endovascular Stent Grafts Market

  • 28.1. Middle East Endovascular Stent Grafts Market Overview
  • 28.2. Middle East Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Endovascular Stent Grafts Market

  • 29.1. Africa Endovascular Stent Grafts Market Overview
  • 29.2. Africa Endovascular Stent Grafts Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Endovascular Stent Grafts Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Endovascular Stent Grafts Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Endovascular Stent Grafts Market Competitive Landscape And Company Profiles

  • 30.1. Endovascular Stent Grafts Market Competitive Landscape
  • 30.2. Endovascular Stent Grafts Market Company Profiles
    • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton, Dickinson and Company (BD) Overview, Products and Services, Strategy and Financial Analysis

31. Endovascular Stent Grafts Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. Terumo Corporation
  • 31.3. Getinge AB
  • 31.4. Cook Group Incorporated
  • 31.5. Merit Medical Systems Inc.
  • 31.6. Biotronik SE & Co KG
  • 31.7. MicroPort Scientific Corporation
  • 31.8. Endologix LLC
  • 31.9. LeMaitre Vascular Inc.
  • 31.10. Lifetech Scientific Corporation
  • 31.11. W. L. Gore & Associates inc.
  • 31.12. Braile Biomedica
  • 31.13. BrosMed Medical BV
  • 31.14. Micro Interventional Devices Inc. (MID)
  • 31.15. Lombard Medical Inc.

32. Global Endovascular Stent Grafts Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Endovascular Stent Grafts Market

34. Recent Developments In The Endovascular Stent Grafts Market

35. Endovascular Stent Grafts Market High Potential Countries, Segments and Strategies

  • 35.1 Endovascular Stent Grafts Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Endovascular Stent Grafts Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Endovascular Stent Grafts Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250423_r33479_Endovascular_Stent_Grafts_GMR_2025